Nicole Junkermann, NJF Capital founder, presents Owkin, an AI medical research start-up whose mission is to use machine learning to develop better drugs for patients. Junkermann has invested in Owkin alongside Brent Hobermann, and they are passionate about the healthcare sector and its growing use of biotech. OWKIN is calling for partners to engage in…